Home | About us | Editorial board | Ahead of print | Current issue | Archives | Search | Submit article | Instructions | Subscribe | Advertise | Contact us |  Login 
National Journal of Maxillofacial Surgery
 
Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 445
 


 
Table of Contents
EDITORIAL
Year : 2012  |  Volume : 3  |  Issue : 1  |  Page : 1  

Innovation in the reconstruction of orofacial region: Challenges and opportunities


Head, Biotechnology & Craniofacial Sciences, Dental School, University of Glasgow, Scotland, United Kingdom

Date of Web Publication9-Oct-2012

Correspondence Address:
Ashraf Ayoub
Head, Biotechnology & Craniofacial Sciences, Dental School, University of Glasgow, Scotland
United Kingdom
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0975-5950.102135

Rights and Permissions

How to cite this article:
Ayoub A. Innovation in the reconstruction of orofacial region: Challenges and opportunities. Natl J Maxillofac Surg 2012;3:1

How to cite this URL:
Ayoub A. Innovation in the reconstruction of orofacial region: Challenges and opportunities. Natl J Maxillofac Surg [serial online] 2012 [cited 2021 Oct 17];3:1. Available from: https://www.njms.in/text.asp?2012/3/1/1/102135

One of the major surgical challenges in the field of regenerative medicine has been the reconstruction of large bony defects in the maxillofacial region. The autogenous bone grafts have always been the gold standard for maxillofacial reconstruction; they facilitate osteoconduction, osteoinduction, and osteogenesis. Osteoconduction occurs when the bone graft material serves as a scaffold for new bone growth that is perpetuated by the native bone. Osteoinduction involves the stimulation of osteoprogenitor cells to differentiate into osteoblasts for the formation of new bone. Osteogenesis occurs when vital osteoblasts originating from the bone graft material contribute to new bone growth. However, the harvesting of autogenous bone graft is associated with donor site morbidities and limited availability. These restrictions inspired the researchers across the world to engineer tissue to replace the lost one. Tissue engineering was initially introduced to describe the synthesis of biological tissue in vitro. Recently, the term "regenerative medicine" has been used to describe the development of technology for the regeneration of tissue in vivo. The objectives of tissue engineering and regenerative medicine are to promote healing, and ideally, true regeneration of a tissue structure and function more predictably and less invasively than the previous grafting techniques.

Bone tissue bioengineering originated with the introduction of 3D biomaterial scaffolds to support the regeneration and to replace the need for autogenous bone graft. However, osteogenesis in these large scaffolds occurred primarily on the outer surfaces, indicating a nonhomogenous distribution of cells and a predominantly osteoconductive rather than osteoinductive pattern of bone formation. The introduction of bone mesenchymal stem cells (MSCs) has been tested in the repair of large bony defects in animal models and in humans, with variable degrees of success.In these studies, expanded MSCs seeded onto various scaffolds were applied in animal models; the reported success was variable and dependent on the animal species, the animal's age, the methodology of MSC culture and its expansion, the cell seeding technique, and the scaffold type and its geometry. The major turning point in the arena of bone reconstruction is the introduction of bone morphogenic proteins (BMPs). BMPs are osteoinductive, and at the level of preclinical research, the use of BMP has shown promising results. The clinical applications are still limited.

One of the major obstacles of a successful bone bioengineering is the compromised vascularity at the graft site due to previous radiotherapy or a vascular disease. In an attempt to solve this problem, a prefabricated tissue engineered graft which was transferred in pedicled flaps has been considered with a moderate degree of success. Further studies are required to improve the blood supply at the surgical site.

There is no doubt that enormous progress has been made over the last 40 years. The application of tissue engineering and prefabrication scaffolding showed great and exciting promising results at preclinical and in some clinical studies. Yet, refinement of the technique, identification of the ideal scaffolding, and improving the vascularity at the surgical site are necessary.

It is our opportunity and responsibility to forge and establish links with the multidisciplinary team of investigators to take the research from the lab to the patients' side, which is essential to fulfil our clinical and academic aspirations.

 
   Authors Top





This article has been cited by
1 Structural mechanism of G protein activation by G protein-coupled receptor
Nguyen Minh Duc,Hee Ryung Kim,Ka Young Chung
European Journal of Pharmacology. 2015; 763: 214
[Pubmed] | [DOI]



 

Top
   
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Authors

 Article Access Statistics
    Viewed2048    
    Printed188    
    Emailed0    
    PDF Downloaded460    
    Comments [Add]    
    Cited by others 1    

Recommend this journal